| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023946 |
| Receipt No. | R000026390 |
| Official scientific title of the study | Follow-up survey 1 year after a current status investigation of external treatment for plaque psoriasis |
| Date of disclosure of the study information | 2016/09/06 |
| Last modified on | 2017/11/17 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Follow-up survey 1 year after a current status investigation of external treatment for plaque psoriasis | |
| Title of the study (Brief title) | Follow-up survey 1 year after a current status investigation of external treatment for plaque psoriasis | |
| Region |
|
|
| Condition | ||
| Condition | psoriasis vulgaris | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The current status investigation of symptoms of plaque psoriasis and their external treatment was conducted and reported by the Topical-therapy Survey Study Group for Psoriasis (TSGP). After 1 year, a follow-up survey was carried out in patients registered for this investigation to obtain evidence concerning the state of treatment and changes in patient satisfaction. |
| Basic objectives2 | Others |
| Basic objectives -Others | Actual condition survey |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Treatments for psoriasis vulgaris.
Satisfaction with treatment. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients who were registered in the TSGP investigation between November 2014 and May 2015, and visited the hospital 4 or more times after the 3-month follow-up
2.Patients who fulfill the criterion 1) in March-June 2016 (as of March 2016, have visited the hospital regularly after the 3-month follow-up and are expected to visit 4 or more times by the end of June) 3.Patients who have used dovobet for more than 1 year 4.Patients who are aged 20 years and have given consent |
|||
| Key exclusion criteria | 1.Patients who are or may be pregnant and those who are breast-feeding
2.Patients judged to be inappropriate as a subject of this study by the investigator physician |
|||
| Target sample size | 250 | |||
| Research contact person | |
| Name of lead principal investigator | Osamu Nemoto |
| Organization | Sapporo dermatology Clinic |
| Division name | Director |
| Address | 5th Floor, H&B Plaza Building, 2-1-1 Minami Sanjo Nishi, Chuo-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-221-8807 |
| sapporo@kojinkai.org | |
| Public contact | |
| Name of contact person | Sayumi Hasegawa |
| Organization | QOL RD Co.,Ltd. |
| Division name | Clinical Research Department CRO Division |
| Address | Front Place Nihonbashi Bldg. 2-14-1, Nihonbashi, Chuo-ku, Tokyo, Japan |
| TEL | 03-6386-8800 |
| Homepage URL | |
| tsgp-study@qol-rd.co.jp | |
| Sponsor | |
| Institute | Topical-therapy Survey Study Group for Psoriasis |
| Institute | |
| Department | |
| Funding Source | |
| Organization | LEO Pharma K.K. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Treatment strategies for psoriasis vulgaris.
Satisfaction with treatment. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026390 |